Barclays Trims Price Targets on Axogen and PulteGroup
Barclays lowered its Axogen target to $50 from $55 while keeping Overweight, and trimmed PulteGroup's to $109 from $110, per Dow Jones Newswires.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Barclays analysts reduced their price target on Axogen (AXGN) to $50 a share from $55, while maintaining an Overweight rating. Dow Jones Newswires reported the change, citing Benzinga's ratings feed.
The same bank also lowered its target on PulteGroup (PHM) to $109 from $110. The Axogen update was published at 13:31 GMT on October 23, 2026, and the PulteGroup one at 13:48 GMT.
why it matters
Single-analyst target changes like these usually affect only the named stocks and rarely move the broader market. For homebuilder and medical-device investors, they show how sell-side expectations are shifting for individual names. The PulteGroup cut is only $1 per share, so it is a minor revision.
tags
instruments
sources
- Axogen Price Target Cut to $50.00/Share From $55.00 by Barclays — Dow Jones Newswires, 23 October 2026 at 13:31 UTC
- PulteGroup Price Target Cut to $109.00/Share From $110.00 by Barclays — Dow Jones Newswires, 23 October 2026 at 13:48 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗